Delivery Order SPE2DB22D1103-SPE2DB25FTQC9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,404.44 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,748.30 to AmerisourceBergen Drug Corp for FORTEO 560 micrograms per 2.24 milliliter pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of October 27, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections valued at $6,024.75, with an ultimate completion date of November 12, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor for medical supply procurement supporting federal healthcare needs. The contract was performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections valued at $88,100.58 on November 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 1, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as the pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FORTEO (Fortified Growth Factor) 560 MCG/2.24 ML pen injections on June 18, 2025, with completion targeted for June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement to support federal medical supply needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,764.33 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of FORTEO 560 MCG/2.24 ML pen injections. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,640.18 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections) on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $8,224.53 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections) with a completion deadline of December 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,057.77 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,413.19 to AmerisourceBergen Drug Corp for FORTEO 560 mcg/2.24 mL pen injections on December 9, 2025, with completion targeted for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric endocrinology/orthopedic pharmaceutical supply under a non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTQC9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,363.00 to AmerisourceBergen Drug Corp for FORTEO 560 mcg/2.24 ml pen injections. This order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price delivery under a competitive, non-set-aside procurement. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The parent IDC vehicle enables the company to supply a comprehensive portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains to support defense health systems worldwide. The firm fixed pricing structure and consistent use of delivery orders under this contract vehicle demonstrate AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/18/25 |